Schroder Investment Management Group Has $88.14 Million Position in CVS Health Corporation (CVS)

Schroder Investment Management Group increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,098,045 shares of the pharmacy operator’s stock after buying an additional 47,003 shares during the quarter. Schroder Investment Management Group owned about 0.11% of CVS Health Corporation worth $88,141,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CVS. Teza Capital Management LLC acquired a new stake in shares of CVS Health Corporation in the 1st quarter valued at $803,000. Morris Capital Advisors LLC boosted its holdings in shares of CVS Health Corporation by 6.1% in the 1st quarter. Morris Capital Advisors LLC now owns 4,270 shares of the pharmacy operator’s stock valued at $335,000 after purchasing an additional 244 shares in the last quarter. Balasa Dinverno & Foltz LLC boosted its holdings in shares of CVS Health Corporation by 3.0% in the 1st quarter. Balasa Dinverno & Foltz LLC now owns 7,514 shares of the pharmacy operator’s stock valued at $590,000 after purchasing an additional 217 shares in the last quarter. Montecito Bank & Trust boosted its holdings in shares of CVS Health Corporation by 31.8% in the 1st quarter. Montecito Bank & Trust now owns 13,523 shares of the pharmacy operator’s stock valued at $1,087,000 after purchasing an additional 3,265 shares in the last quarter. Finally, Allegis Investment Advisors LLC boosted its holdings in shares of CVS Health Corporation by 87.0% in the 1st quarter. Allegis Investment Advisors LLC now owns 23,357 shares of the pharmacy operator’s stock valued at $1,834,000 after purchasing an additional 10,866 shares in the last quarter. 81.42% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Corporation (CVS) opened at $70.38 on Tuesday. CVS Health Corporation has a 12-month low of $66.45 and a 12-month high of $84.72. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $71,290.00, a price-to-earnings ratio of 12.38, a P/E/G ratio of 1.21 and a beta of 0.86.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same period last year, the company posted $1.64 EPS. The business’s quarterly revenue was up 3.5% on a year-over-year basis. equities research analysts anticipate that CVS Health Corporation will post 5.9 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.84%. The ex-dividend date was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio (DPR) is presently 41.32%.

CVS has been the topic of a number of research analyst reports. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Wolfe Research downgraded CVS Health Corporation from an “outperform” rating to a “market perform” rating and reduced their target price for the company from $89.00 to $82.00 in a report on Monday, August 14th. Robert W. Baird reaffirmed an “outperform” rating and issued a $90.00 target price on shares of CVS Health Corporation in a report on Monday, August 14th. Citigroup Inc. reduced their target price on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Thursday, August 17th. Finally, Loop Capital initiated coverage on CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price on the stock. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company’s stock. CVS Health Corporation presently has an average rating of “Buy” and an average target price of $85.82.

In other news, insider Larry J. Merlo sold 241,150 shares of CVS Health Corporation stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total value of $20,032,330.50. Following the completion of the transaction, the insider now directly owns 299,255 shares of the company’s stock, valued at approximately $24,859,112.85. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health Corporation stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the transaction, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The disclosure for this sale can be found here. Over the last three months, insiders sold 714,125 shares of company stock valued at $58,119,381. Corporate insiders own 0.61% of the company’s stock.

WARNING: This report was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.com-unik.info/2017/11/21/schroder-investment-management-group-has-88-14-million-position-in-cvs-health-corporation-cvs.html.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

What are top analysts saying about CVS Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit